logo

For the Inventor, By the Inventor

Seoul, South Korea

Choongwae Pharma Corporation


USPTO Granted Patents = 25

% Expired Patents = 56.0



Forward Citations = 194

Loading Chart...
Loading Chart...

40 inventors (with patents filed for the assignee):

goldMedal Jae Uk Chung (16 out of 16 patents)

silverMedal Michael S Kahn (16 out of 52 patents)

bronzeMedal Masakatsu Eguchi (14 out of 28 patents)

4.  Sung Hwan Moon (13 out of 21 patents)

5.  Kwang Won Jeong (12 out of 13 patents)

6.  Sung Chan Lee (11 out of 15 patents)

7.  Cu Nguyen (11 out of 11 patents)

8.  Soo Jin Lee (4 out of 10 patents)

9.  Kyung-Yun Jung (2 out of 2 patents)

10.  Sang-Heon Lee (2 out of 2 patents)

11.  Kye-Hyun Kim (2 out of 2 patents)

12.  Seungjoo Lee (1 out of 14 patents)

13.  Sang-Hwi Lee (1 out of 2 patents)

14.  Jin-Woo Choi (1 out of 29 patents)

15.  Mikyoung Hahn (1 out of 1 patent)


Core Competencies:
Reverse-Turn Mimetics
Cancer Treatment
Orally Disintegrating Dosage
Beta-Strand Mimetics
Alpha-Helix Mimetics
Tetrafluorobenzylaniline
Paclitaxel Composition
Liver Protection Activity
Stem Cell Growth
Optically Active Derivatives

25 patents:

1. 10548847 - Composition for manufacturing orally disintegrating dosage form to protect coating layer of active substance (2020-02-04),
2. 8729262 - Reverse-turn mimetics and method relating thereto (2014-05-20),
3. 8318738 - Reverse-turn mimetics and method relating thereto (2012-11-27),
4. 8293743 - Substituted imidazo[1,2-A]pyrazine derivatives as alpha-helix mimetics and method relating to the treatment of cancer stem cells (2012-10-23),
5. 8138337 - Reverse-turn mimetics and method relating thereto (2012-03-20),
6. 8106049 - Reverse-turn mimetics and method relating thereto (2012-01-31),
7. 8101751 - Reverse-turn mimetics and method relating thereto (2012-01-24),
8. 8080657 - Compounds of reverse turn mimetics and the use thereof (2011-12-20),
9. 8071764 - Compounds of reverse turn mimetics and the use thereof (2) (2011-12-06),
10. 8049008 - Reverse-turn mimetics and method relating thereto (2011-11-01),
11. 7932384 - Reverse-turn mimetics and method relating thereto (2011-04-26),
12. 7671054 - Reverse-turn mimetics and method relating thereto (2010-03-02),
13. 7662960 - Beta-strand mimetics and method relating thereto (2010-02-16),
14. 7585862 - Reverse-turn mimetics and method relating thereto (2009-09-08),
15. 7576084 - Reverse-turn mimetics and method relating thereto (2009-08-18),
Company Overview
Choongwae Pharma Corporation is a South Korean company specializing in the development and manufacturing of pharmaceutical products. The organization focuses on innovative solutions in the healthcare sector, particularly in areas such as prescription medications and over-the-counter drugs. With a commitment to research and development, Choongwae Pharma aims to enhance therapeutic options and improve patient outcomes. The company operates primarily within the Asian market, contributing to advancements in medical treatments and healthcare solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

25 Patents

#193 in Seoul

#526 in South Korea

#25,730 in the World

Seoul, KR
Seoul, South Korea

Choongwae Pharma Corporation

Forward Citations = 194

40 inventors:

goldMedal Jae Uk Chung (16 out of 16 patents)

silverMedal Michael S Kahn (16 out of 52 patents)

bronzeMedal Masakatsu Eguchi (14 out of 28 patents)

4.  Sung Hwan Moon (13 out of 21 patents)

5.  Kwang Won Jeong (12 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Choongwae Pharma Corporation. Retrieved from https://idiyas.com/company/choongwae-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…